Randy Vivian

发表

Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®.

T. Appleby, G. Cheng, Tetsuya Kobayashi, 2019, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: core region.

M. Desai, Luong K. Tsai, Kirsten M. Stray, 2014, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350).

M. Desai, Luong K. Tsai, S. Swaminathan, 2014, Bioorganic & medicinal chemistry letters.